Pinazepam


Full Generic Medicine Info
Dosage/Direction for Use

Oral
Anxiety
Adult: 10 mg daily in 2 divided doses; may increase to 20 mg daily in severe cases.
Administration
May be taken with or without food.
Contraindications
Myasthenia gravis, acute narrow-angle glaucoma. Pregnancy.
Special Precautions
Patient with CV disease, blood dyscrasias. Hepatic impairment.
Adverse Reactions
Blood and lymphatic system disorders: Rarely, bone marrow depression. Cardiac disorders: Palpitations, tachycardia. Gastrointestinal disorders: Gastrointestinal disorders. Hepatobiliary disorders: Rarely, liver damage. Musculoskeletal and connective tissue disorders: Muscle weakness. Nervous system disorders: Ataxia, dizziness, drowsiness. Psychiatric disorders: Confusion. Skin and subcutaneous tissue disorders: Rash.
Drug Interactions
Enhances the sedative effects of other CNS depressant drugs (e.g. opioids, sedating antihistamines, barbiturates).
Food Interaction
Increases the CNS depressant effects of alcohol.
Action
Pinazepam, a long-acting benzodiazepine, has general properties similar to diazepam but with less toxicity. Its action mainly involves modification in the limbic system region. Pinazepam appears to be associated with a particularly low hypnotic effect and a limited motor coordination impairment. It also shows less cortical activity at the anxiolytic level than does diazepam on EEG.
Absorption: Rapidly absorbed from the gastrointestinal tract.
Metabolism: Metabolised via N-1 dealkylation and C-3 hydroxylation.
CIMS Class
Anxiolytics
ATC Classification
N05BA14 - pinazepam ; Belongs to the class of benzodiazepine derivatives anxiolytics. Used in the management of anxiety, agitation or tension.
Disclaimer: This information is independently developed by CIMS based on pinazepam from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in